SI-BONE CEO Laura Francis sells 16,854 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SI-BONE, Inc. Chief Executive Officer Laura Francis reported six direct sales totaling 16,854 shares on November 16–17, 2026. Five November 16 sales were required to cover tax withholding tied to restricted stock unit vesting and were described as not discretionary. Her 1,901-share November 17 sale had a weighted average price of $23.1763 per share and was made under a 10b5-1 trading plan dated June 13, 2025. Separately, The David & Laura Joint Rev Tr. was listed as holding 304,256 shares on November 16.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F7, F8, F9 | 1,901 | $23.1763 | $44K |
| Sale | Common Stock F1, F2 | 3,892 | $23.3331 | $91K |
| Sale | Common Stock F1, F3 | 2,235 | $23.3256 | $52K |
| Sale | Common Stock F1, F4 | 3,203 | $23.3229 | $75K |
| Sale | Common Stock F1, F5 | 3,651 | $23.3321 | $85K |
| Sale | Common Stock F1, F6 | 1,972 | $23.3191 | $46K |
| Holding | Common Stock F10 | -- | -- | -- |
Footnotes (10)
- F1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- F10. Shares held by The David & Laura Joint Rev Tr.
- F2. This transaction was executed in multiple trades at prices ranging from $23.25 USD to $23.42 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. This transaction was executed in multiple trades at prices ranging from $23.28 USD to $23.40 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. This transaction was executed in multiple trades at prices ranging from $23.30 USD to $23.44 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. This transaction was executed in multiple trades at prices ranging from $23.26 USD to $23.42 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. This transaction was executed in multiple trades at prices ranging from $23.27 USD to $23.38 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated June 13, 2025.
- F8. This transaction was executed in multiple trades at prices ranging from $23.03 USD to $23.43 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. Includes 326,327 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
Key Terms
sell to cover transaction financial
restricted stock units financial
10b5-1 trading plan regulatory
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.